On November 21, 2022, CytoDyn Inc. and Nitya G. Ray, Ph.D., the Company's Chief Technology Officer, agreed that Dr. Ray will resign from his role at the Company, effective immediately.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.14 USD | +1.27% | -6.67% | -28.21% |
Apr. 15 | CytoDyn Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024 | CI |
Mar. 05 | Transcript : CytoDyn Inc. - Special Call |
1st Jan change | Capi. | |
---|---|---|
-28.21% | 139M | |
-3.46% | 102B | |
+1.41% | 96.09B | |
+2.13% | 22.28B | |
-15.84% | 21.4B | |
-9.19% | 18.14B | |
-39.98% | 17.02B | |
-14.65% | 16.09B | |
+4.39% | 13.83B | |
+31.35% | 11.97B |
- Stock Market
- Equities
- CYDY Stock
- News CytoDyn Inc.
- Nitya G. Ray Resigns as Chief Technology Officer of CytoDyn Inc